Bristol Myers pulls Opdivo for use in liver cancer amid broader FDA scrutiny of speedy approvals July 26, 2021 Auto Bot BioPharma, biopharma nl, Bristol-Myers Squibb, Clinical Trials, FDA, Legal, New York, Opdivo, Pharma 0 Bristol Myers Squibb blockbuster drug Opdivo is being pulled from the market after failing to meet the main goal of a confirmatory study. The voluntary withdrawal comes amid broader FDA scrutiny of cancer drugs that were given accelerated approval.